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Chapter 7
Isolation and Phenotyping of Adult Mouse Microglial Cells
Kathleen Grabert and Barry W. McColl
Abstract
Microglia are the resident macrophages of the central nervous system parenchyma and fulfill crucial roles 
in brain development, homeostasis, and inflammation. The isolation of a pure microglia population from 
brain tissue enables the examination of microglial phenotypes without the interference of other cell popu-
lations. Microglial extractions from the neonatal brain have been described in various protocols, yet the 
more established and complex adult mouse brain poses a greater challenge. Here we describe a refined 
protocol including enzymatic and mechanical dissociation of adult mouse brain tissue and removal of 
myelin by Percoll density gradient. Microglial cells were subsequently extracted by an immunomagnetic 
approach. This isolation procedure enables the use of functionally viable cells for various applications such 
as cell culture, flow cytometry, functional assays including bacteria- or bead-based phagocytosis, stimula-
tion assays, and transcriptome profiling techniques such as qRT-PCR and microarray/RNA sequencing.
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1 Introduction
Microglia, specially adapted tissue-resident macrophages of the 
central nervous system (CNS), are highly dynamic and vital play-
ers in CNS physiology and neuroimmune function. Their multi-
functional role begins during embryonic and early postnatal 
development sculpting the developing CNS [1] by supporting 
synaptic maturation of active neurons through synaptic pruning 
and remodeling [2–4]. In adulthood under steady-state condi-
tions microglia function further extends to include maintenance 
of brain homeostasis by continuous surveillance of their local 
environment and neural parenchyma, examining synaptic activity 
[5], and phagocytic removal of cell debris [6]. As one of the earli-
est responders to sterile and microbial inflammatory stimuli, acti-
vated microglia migrate to sites of injury/infection and initiate 
neuroimmune and inflammatory responses involving the internal-
ization of damaged cells or invading pathogens, and the synthesis 
of a variety of immunoregulatory and inflammatory components 
[7–9] for the protection and repair of the brain [10, 11]. 
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Dysregulation of microglial activity is also increasingly implicated 
in a range of neurological conditions [12, 13].
Yolk sac-derived microglia migrate into the brain during early 
development and are evident from embryonic day (E) 9.5 in mice 
[14] and soon after birth these cells comprise 5–12% of the total 
number of cells [15]. The investigation of the phenotypes and cru-
cial functions of microglia in response to distinct physiological and 
pathological conditions, including ageing, has been constrained by 
the considerable challenge to directly isolate pure populations of 
microglia from the adult brain. Over the last 20 years, a range of 
methods have evolved from initial in  vitro culture systems of 
microglia purification from rodent neonates [16, 17] and early 
postnatal brains [18] to adult microglia in rats [19, 20] and humans 
[21, 22] as well as more recently the generation of microglia 
derived from induced pluripotent stem cells (iPSC) [23, 24]. Due 
to the low abundance of these cells the strategy of microglial isola-
tion has become crucial to achieve sufficient numbers and with 
minimal deviation from the microglial in vivo signature. The latter 
is crucial as it has been reported that a few hours after isolation and 
culture the unique signature of microglia is downregulated and 
ultimately their functional phenotype altered [25, 26]. However, 
efforts are made to identify key factors, which promote an in vivo 
phenotype in culture [27, 28] after the isolation as described in 
this protocol. In addition to the investigation of whole-brain 
microglia, the isolation of cells was furthermore applied to study 
discrete brain regions [29] and single cells [30] to identify discrete 
microglia phenotypes and their contribution to age-related neuro-
degenerative diseases.
In general, the isolation of microglia from the adult mouse 
brain as described here is composed of three steps. The brain tissue 
is first dissociated with enzymes and subsequently homogenized by 
a Dounce homogenizer. To facilitate the separation of microglia, 
myelin is removed by a two-layer density gradient, followed by the 
labeling of microglia with CD11b immunomagnetic beads and 
magnetic separation of CD11b-positive microglia from the remain-
ing brain cell suspension. Once isolated and cell purities and yield 
are confirmed, extracted microglial cells are suitable for a range of 
downstream phenotyping and functional applications including 
flow cytometry, cell culture, stimulation and phagocytosis assays, 
and -omics profiling.
2 Materials
 1. Perfusion pump.
 2. Tissue culture hood.
 3. Incubating oven.
 4. 15 mL Dounce homogenizer.
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 5. Falcon tubes and microtubes.
 6. 5, 10, and 20 mL stripettes.
 7. Centrifuge.
 8. LS columns (Miltenyi Biotec).
 9. MACSmix Tube Rotator.
 10. MidiMACS separator and MultiStand.
 1. 1× Hanks’ balanced salt solution (HBSS) without calcium and 
magnesium.
 2. 10× HBSS.
 3. Percoll.
 4. CD11b human/mouse MicroBeads.
 5. Purified anti-mouse CD16/CD32 (Fc block).
 6. Anti-mouse antibodies against CD11b, CD45, and F4/80.
 1. Physiological saline: 0.9% Saline treated with 0.1% diethyl 
pyrocarbonate (DEPC), store at 4 °C.
 2. Enzyme cocktail: 10 mL of enzyme cocktail contains the fol-
lowing ingredients and stock concentrations: 50 μL of 50 U/
mL collagenase D, 10 μL of 100 μg/mL Nα-Tosyl-L-lysine 
chloromethyl ketone hydrochloride, 50  μL of 5  U/mL 
DNaseI, and 250  μL of 340  U/mL dispase in 9.64  mL 
HBSS. Prepare stock concentration of enzymes according to 
the manufacturer’s instruction. Enzyme mix was prepared 
fresh or stored in appropriate aliquots at −20 °C.
 3. 10% Fetal bovine serum (FBS): Make up 10% FBS in 
HBSS. Prepare fresh on the day or freeze in aliquots at −20 °C.
 4. Isotonic Percoll: Prepare isotonic Percoll by adding 1 volume 
of 10× HBSS to 9 volumes of Percoll. Prepare fresh each time.
 5. 35% Percoll: 16 mL is required per whole brain. Add 5.6 mL 
of isotonic Percoll to 10.4 mL 1× HBSS. Prepare fresh each 
time.
 6. 0.5  M Ethylenediaminetetraacetic acid (EDTA) stock: Add 
56 g NaOH to 800 mL water. Weigh 186.12 g of EDTA diso-
dium salt (or 146.2 g of EDTA anhydrous) and add to NaOH 
solution. Let dissolve, adjust pH to 7.5, and top up to 1 L 
with water.
 7. Separation buffer: 1× PBS, pH 7.2, 0.5% bovine serum albu-
min (BSA, low endotoxin), 2 mM EDTA. Add 0.5 g BSA to 
100 mL PBS (pH 7.2) and add 400 μL of 0.5 M EDTA stock 
solution. Store at 4 °C.
 8. Flow cytometry buffer: Add 0.1  g BSA (low endotoxin) to 
100 mL PBS (without calcium and magnesium). Store at 4 °C.
2.1 Reagents
2.2 Solutions
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3 Methods
Carry out all procedures at 4 °C and use ice-cold reagents unless 
otherwise specified (see Note 1). The isolation procedure is sum-
marized in Fig. 1.
 1. Perfuse animals transcardially with physiological saline 
(10 mL/min) until exudate runs clear (see Note 2).
3.1 Perfusion 
and Isolation of Mouse 
Brain
Y
CD11b magnetic 
beads
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brain/region
Enzymatic dissociation
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immunomagnetic beads
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Layers after 
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~
~
Y
Y
~
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Brain cell 
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Fig. 1 Schematic workflow of the microglia isolation process
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 2. Remove brain and transfer into 50 mL Falcon tube containing 
10  mL HBSS either as whole brain, hemisphere, or brain 
region.
 3. Finely mince brain tissue with a round-edge blade scalpel to 
allow fast cooling of the tissue.
 4. Spin minced brain tissue for 5 min at 400 × g and aspirate 
supernatant.
 1. Add enzyme cocktail to the minced whole-brain tissue (10 mL) 
or brain hemisphere/brain region (5 mL) (see Note 3).
 2. Incubate for 1 h at 37 °C under gentle rotation (see Note 4).
 3. Transfer the digested brain tissue to a 15 mL Dounce homog-
enizer and dissociate on ice with 20 passes using the large 
clearance pestle (see Note 5).
 4. Transfer the homogenized brain cell suspension to an equal 
volume of 10% FBS.
 5. Centrifuge for 5  min at 4  °C and 400  ×  g (no brake) and 
remove the supernatant.
 1. Resuspend the cell suspension from whole brain in 16 mL or 
brain hemisphere/region in 8 mL of 35% Percoll (see Note 6).
 2. Split only the whole brain in 2 × 8 mL.
 3. Carefully overlay each sample with 5 mL 1× HBSS and leave 
samples to rest for 5 min on ice (see Note 7).
 4. Spin samples for 45 min at 4 °C and 800 × g (no brake) and 
subsequently different layers can be observed (see Fig. 1).
 5. Aspirate the supernatant including the myelin layer carefully, 
leaving only the pelleted mixed brain cells.
 6. Wash the cell pellet in 1 mL 1× HBSS and transfer into a new 
tube containing 4 mL 1× HBSS.
 7. Spin for 5 min at 4 °C and 400 × g and remove supernatant.
 1. Resuspend the cell pellet in 90 μL separation buffer and trans-
fer into a microtube.
 2. Add 10 μL anti-CD11b MicroBeads and incubate the cell-bead 
mix for 15 min at 4 °C under gentle rotation (see Note 8).
 3. Meanwhile place LS single-use columns in magnet and wash 
through with 3 mL of separation buffer.
 4. Add 500 μL separation buffer to bead-cell-suspension, apply 
onto LS column, and collect flow-through (see Note 9).
 5. Wash the columns three times with 3 mL separation buffer (see 
Note 10).
3.2 Enzymatic 
Dissociation 
and Homogenization
3.3 Myelin-Free 
Mixed Brain Cell 
Suspension by Density 
Gradient
3.4 Immunomagnetic 
 Bead Separation
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 6. Remove LS columns from the magnet and place into a 15 mL 
tube.
 7. Add 5  mL of separation buffer and flush out bead-bound 
microglial cells by firmly pushing the plunger.
 8. Pellet the cells for 5 min at 400 g and 4 °C.
 1. Resuspend purified microglia in flow cytometry buffer and 
incubate with 1 μg/mL anti-mouse CD16/CD32 for 20 min 
at room temperature (see Note 11).
 2. Spin at 400 × g for 5 min and remove supernatant.
 3. Resuspend cells in fluorophore-conjugated antibodies for the 
protein of interest (here CD11b, CD45, F4/80) for 20 min in 
the dark at room temperature (see Note 12).
 4. Wash samples for 5 min at 400 g and resuspend samples in an 
appropriate volume of flow cytometry buffer.
4 Notes
 1. All procedures should be performed under the tissue culture 
hood, particularly if intending to use isolated cells for subse-
quent cell culture.
 2. By performing perfusions blood is removed from the circula-
tion and minimizes the contamination with red blood cells, 
which has been observed to reduce the efficiency of the bead- 
based microglia separation from brain cell suspension, and 
other immune cells such as CD11b+ leukocytes.
 3. To shorten the time frame of the overall procedure the brain 
tissue digest was performed without and with different dura-
tions of enzyme mix. Our results (see Fig.  2) demonstrated 
that an enzymatic digestion improved yield of microglia.
 4. Rotating movement is not necessarily required; the pieces of 
brain tissue should be under gentle movement to avoid pellet-
ing and insufficient enzymatic digestion.
 5. Brain cell suspension should have a homogenous and milky 
appearance after Dounce homogenization.
 6. To achieve a good separation of mixed brain cells from the 
myelin the ratio between tissue and Percoll volume is crucial. 
A surplus of tissue in the gradient will impair the yield and 
purity of microglial cells.
 7. Resting the samples enables the settling and strengthening of 
the different layers.
 8. The application of CD11b MicroBeads (clone: M1/70) will 
lead to the reduced binding capacity of any CD11b flow cyto-
metric antibodies if the clone of both antibodies is the same 
3.5 Flow Cytometric 
Analysis
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Fig. 2 Effect of enzymatic treatment. The application and duration of the enzymatic digestion of whole-brain 
tissue resulted in variance in the yield of extracted microglial cells
and therefore competing for binding positions. Difference in 
a lower CD11b staining of positive selected microglia is evi-
dent when compared to pre-sorted microglia within the 
mixed brain cell suspension after myelin removal (see Fig. 3). 
In view of recent data [27, 31, 32] other antibodies (e.g., 
TMEM119 or FCRLs) could be applied for microglia isola-
tion as CD11b does not necessarily label microglia only, par-
ticularly in inflamed conditions.
 9. Flow-through containing depleted fraction can be collected to 
confirm negligible loss of microglia or to collect information 
from remaining cells contained in the brain cell suspension.
 10. Let wash buffer run through completely each time for maxi-
mum washing efficiency.
 11. Nonselected and pre-sorted samples can be used for flow 
cytometry to compare to purified microglia and for the valida-
tion of specificity.
 12. Depending on the protein of interest, intracellular staining or 
a secondary antibody may be required.
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